Sialylation: an Avenue to Target Cancer Cells

Pathology and Oncology Research

Volumn 22, Issue 3, 2016, Pages 443-447

  Vajaria, Bhairavi N ^a   Patel, Kinjal R ^a   Begum, Rasheedunnisa ^b   Patel, Prabhudas S ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

Sialic acid; Sialidase; Sialoproteins; Sialylation; Sialyltransferase

Indexed keywords

AL 10; CARBOHYDRATE ANTIGEN; COMPLEMENTARY RNA; ENZYME INHIBITOR; GEFITINIB; GLYCOSYLTRANSFERASE INHIBITOR; KI 8110; LIPID; LITHOCHOLIC ACID; MESSENGER RNA; OLIGOSACCHARIDE; OSELTAVIMIR PHOSPHATE; PROTEIN NEU1; PROTEIN NEU2; PROTEIN NEU3; PROTEIN NEU4; SHORT HAIRPIN RNA; SIALIC ACID; SIALIC ACID DERIVATIVE; SIALIDASE; SIALIDASE INHIBITOR; SIALOGLYCOPROTEIN; SIALOPROTEIN; SIALYLTRANSFERASE; SOYASAPONIN I; SUGAR; UNCLASSIFIED DRUG; ZANAMIVIR; ZP 103; N ACETYLNEURAMINIC ACID;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL; CANCER INFILTRATION; CANCER INHIBITION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; METASTASIS INHIBITION; MOUTH CANCER; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVIEW; SIALYLATION; UTERINE CERVIX CANCER; ANIMAL; CARCINOGENESIS; METABOLISM; NEOPLASM; PATHOLOGY; PROGNOSIS;

ANIMALS; CARCINOGENESIS; HUMANS; N-ACETYLNEURAMINIC ACID; NEOPLASM METASTASIS; NEOPLASMS; NEURAMINIDASE; PROGNOSIS; SIALOGLYCOPROTEINS; SIALYLTRANSFERASES;

EID: 84950286426     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-015-0033-6     Document Type: Review

References (35)

1. Vajaria BN, Patel KR, Begum R, Patel JB, Shah FD, Shukla SN, Patel PS (2012) Glycoprotein electrophoretic patterns have potential to monitor changes associated with neoplastic transformation in oral cancer. Int J Biol Markers 27:e247–e256
2. Tian Y, Estena FJ, Song J, Zhang H (2012) Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry. Mol Cell Proteomics 11:M111.011403
3. Shah MH, Telang SD, Shah PM, Patel PS (2008) Tissue and serum alpha 2–3- and alpha 2–6-linkage specific sialylation changes in oral carcinogenesis. Glycoconj J 25:279–290
4. Cylwik B, Chrostek L, Szmitkowski M (2005) Diagnostic value of total and lipid bound sialic acid in malignancies. Pol Merkur Lekarski 19:237–241
5. Bose SC, Gokhale PV, Dwivedi S, Singh M (2013) Quantitative evaluation and correlation of serum glycoconjugates: protein bound hexoses, sialic acid and fucose in leukoplakia, oral sub mucous fibrosis and oral cancer. J Nat Sci Biol Med 4:122–125
6. Yakob M, Fuentes L, Wang MB, Abemayor E, Wong DTW (2014) Salivary biomarkers for detection of oral squamous cell carcinoma. Current state and recent advances. Curr Oral Health Rep 1:133–141
7. Cheng YSL, Rees T, Wright J (2014) A review of research on salivary biomarkers for oral cancer detection. Clin Transl Med 3:1–10
8. Ozturk LK, Emekli-Alturfan E, Kasikcy E, Demir G, Yarat A (2011) Salivary total sialic acid levels increase in breast cancer patients: a preliminary study. Med Chem 7:443–447
9. Vajaria BN, Patel KR, Begum R, Patel JB, Shah FD, Joshi GM, Patel PS (2014) Salivary glyco-sialylation changes monitors oral carcinogenesis. Glycoconj J 31:649–659
10. Pelak MJ, Jarosz B, Straczynska-Niemiec A, Krawczyk P, Skoczylas P, Pecka KM, Snietura M, Szumilo J, Trojanowski T (2014) The presence and clinical implications of α-2,6-galactose-linked sialic acids in non-small-cell lung cancer brain metastases - preliminary study. Folia Histochem Cytobiol 52:104–111
11. Martinez-Duncker I, Salinas-Marin R, Martinez-Duncker C (2011) Towards invivo imaging of cancer sialylation. Int J Mol Imaging 2011:283497
12. Lu DY, Lu TR (2012) Development of antimetastatic drugs by targeting tumor sialic acids. Sci Pharm 80:497–508
13. Lu DY, Xu J, Lu TR, Wu HY, Xu B (2013) Inhibition of several antineoplastic drugs on serum sialic acid levels in mice bearing tumors. Sci Pharm 81:223–231
14. Miyagi T, Yamaguchi K (2012) Mammalian sialidase: physiological and pathological roles in cellular functions. Glycobiology 22:880–896
15. Uemura T, Shiozaki K, Yamaguchi K, Miyazaki S, Satomi S, Kato K, Sakuraba H, Miyagi T (2009) Contribution of sialidase NEU1 to suppression of metastasis of human Colon cancer cells through desialylation of integrin beta4. Oncogene 28:1218–1229
16. Silvestri I, Testa F, Zappasodi R, Cairo CW, Zhang Y, Lupo B, Galli R, Nicola MD, Venerando B, Tringali C (2014) Sialidase NEU 4 is involved in glioblastoma stem cell survival. Cell Death Dis 5:e1381
17. O’Shea LK, Abdulkhalek S, Allison S, Neufeld RJ, Szewczuk MR (2014) Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) disables cancer cells survival in human pancreatic cancer with acquired chemoresistance. Onco Targets Ther 7:117–134
18. Li X, Zhang L, Shao Y, Liang Z, Shao C, Wang B, Guo B, Li N, Zhao X, Li Y, Xu D (2011) Effects of human plasma membrane associated sialidase siRNA on prostate cancer invasion. Biochem Biophys Res Commun 416:270–276
19. Tsai CS, Yen HY, Lin MI, Tsai TI, Wang SY, Huang WI, Hsu TL, Cheng YS, Fang JM, Wong CH (2013) Cell-permeable probe for identification and imaging of human sialidases. Proc Natl Acad Sci U S A 110:2466–2471
20. Harduin-Lepers A, Krzewinski-Recchi MA, Colomb F, Foulquier F, Groux-Degrootes DP (2012) Sialyltransferase functions in cancer. Front Biosci 4:499–515
21. Hauselmann I, Borsig L (2014) Altered tumor cell-glycosylation promotes metastasis. Front Oncol 4:28
22. Hakomori S (2001) Tumor associated carbohydrate antigens defining tumor malignancy: basis for development of anticancer vaccines. Adv Exp Med Biol 491:369–402
23. Skropeta D, Schwörer R, Haag T, Schmidt RR (2004) Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues. Glycoconj J 21:205–219
24. Chen JY, Tang YA, Huang SM, Juan HF, Wu LW, Sun YC, Wang SC, Wu KW, Balraj G, Chang TT, Li WS, Cheng HC, Wang YC (2011) A novel sialyltransferase inhibitor suppresses Fak/paxillin signaling and cancer angiogenesis and metastatic pathways. Cancer Res 71:473–483
25. Nakano T, Matsui T, Ota T (1996) Benzyl-alpha-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16BL6 melanoma cells. Anticancer Res 16:3577–3584
26. Preidl JJ, Gnanapragassam VS, Lisurek M, Saupe J, Horstkorte R, Rademann J (2014) Fluorescent mimetics of CMP-Neu5Ac are highly potent, cell-permeable polarization probes of eukaryotic and bacterial sialyltransferases and inhibit cellular sialylation. Anqew Chem Int Ed Engl 53:5700–5705
27. Park JJ, Yi JY, Jin YB, Lee YJ, Lee JS, Lee YS, Ko YG, Lee M (2012) Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. Biochem Pharmacol 83:849–857
28. Rillahan CD, Antonopoulos A, Lefort CT, Sonon R, Azadi P, Ley K, Dell A, Haslam SM, Paulson JC (2012) Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. Nat Chem Biol 8:661–668
29. Brown JR, Crawford BE, Esko JD (2007) Glycan antagonists and inhibitors: a fount for drug discovery. Crit Rev Biochem Mol Biol 42:481–515
30. Ko K, Furukawa K, Takahashi T, Urano T, Sanai Y, Nagino M, Nimura Y, Furukawa K (2006) Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers. Oncogene 25:6924–6935
31. Gu Y, Zhang J, Mi W, Yang J, Han F, Lu X, Yu W (2008) Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells. Breast Cancer Res 10:R1
32. Zhu Y, Srivatana U, Ullah A, Gagneja H, Berenson CS, Lance P (2001) Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim Biophys Acta 1536:148–160
33. Saldova R, Fan Y, Fitzpatrick JM, Watson RW, Rudd PM (2011) Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology 21:195–205
34. Almaraz RT, Tian Y, Bhattarcharya R, Tan E, Chen SH, Dallas MR, Chen L, Zhang Z, Zhang H, Konstantopoulos K, Yarema KJ (2012) Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis. Mol Cell Proteomics 11:M112.017558
35. Bull C, Boltje TJ, Wassink M, de Graaf AM, van Delft FL, den Brok MH, Adema GJ (2013) Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion, migration, and in vivo tumor growth. Mol Cancer Ther 12:1935–1946